Hyperhomocyst(e)inemia and hemostatic factors: The atherosclerosis risk in communities study

Annals of Epidemiology

Volumn 12, Issue 4, 2002, Pages 228-236

  Schreiner, Pamela J ^a   Wu, Kenneth K ^b   Malinow, M Rene ^c   Stinson, Valarie L ^d   Szklo, Moyses ^e   Nieto, F Javier ^e   Heiss, Gerardo ^f  

^a UNIVERSITY OF MINNESOTA   (United States)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f The University of North Carolina at Chapel Hill   (United States)

Author keywords

Atherosclerosis; Hemostasis; Homocysteine

Indexed keywords

ANTIGEN; BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; D DIMER; FIBRINOGEN; FOLIC ACID; HOMOCYSTEINE; LIPOPROTEIN A; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ETHNOLOGY; FEMALE; FOOD AND DRUG ADMINISTRATION; GRAIN; HEMATOCRIT; HEMOSTASIS; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEURAL TUBE DEFECT; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; RISK; SAMPLE; SEX DIFFERENCE; SMOKING; THROMBOCYTE COUNT;

AGE FACTORS; ARTERIOSCLEROSIS; BLOOD COAGULATION FACTORS; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HEMOSTASIS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; SEX FACTORS; SMOKING;

EID: 0036240451     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(01)00311-8     Document Type: Article

References (55)

1. Hyperhomocysteinemia; An independent risk factor for vascular disease
2. Vitamin intake; A possible determinant of plasma homocyst(e)ine among middle-aged adults
3. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
4. Hyperhomocyst(e)inaemia; An independent risk factor for intermittent claudication
5. 12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency
6. Homocysteinemia due to folate deficiency
7. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
8. Serum total homocysteine and coronary heart disease
9. Plasma homocyst(e)ine levels in men with premature coronary artery disease
10. Homocyst(e)inemia in daily practice; Levels in coronary artery disease
11. Homocysteine and myocardial infarction
12. Methionine intolerance; A possible risk factor for coronary artery disease
13. The pathogenesis of coronary artery disease; A possible role for methionine metabolism
14. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
15. Hyperhomocysteinaemia in stroke; Prevalence, cause, and relationships to type of stroke and stroke risk factors
16. Moderate homocysteinemia - A possible risk factor for arteriosclerotic cerebrovascular disease
17. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease
18. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease
19. Prospective studies of homocysteine and cardiovascular disease
20. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
21. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke
22. 6 and risk of myocardial infarction in US physicians
23. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study
24. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial
25. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins; The Atherosclerosis Risk in Communities (ARIC) Study
26. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults; The Atherosclerosis Risk in Communities Study
27. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis
28. Endothelial cell damage and homocysteine
29. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
30. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
31. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
32. Activation of endogenous factor V by a homocysteine- induced vascular endothelial cell activator
33. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor
34. The Atherosclerosis Risk in Communities (ARIC) Study; Design and Objectives
35. Carotid atherosclerosis measured by B-mode ultrasound in populations; Associations with cardiovascular risk factors in the ARIC Study
36. Association of coagulation factors and inhibitors with carotid artery atherosclerosis; Early results of the Atherosclerosis Risk in Communities (ARIC) Study
37. ARIC Hemostasis Study-I. Development of a blood collection and processing system suitable for multicenter hemostatic studies
38. Correlation of specific platelet activation markers with carotid arterial wall thickness
39. Association of fibrinolytic parameters with early atherosclerosis; The ARIC Study
40. Isolation and characterization of the two major apoproteins in human lipoprotein
41. Human plasma lipoprotein[a]; Structural properties
42. Oxidation of low density lipoprotein by thiols; Superoxide-dependent and -independent mechanisms
43. Schlegel, et al. Promotion of vascular smooth muscle cell growth by homocysteine; A link to atherosclerosis
44. Identification of mechanisms that may modulate the role of lipoprotein(a) in thrombosis and atherogenesis
45. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin; A potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism
46. Endothelium-derived relaxing factor modulates the atherothrombogenic effects of homocysteine
47. Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum
48. Evidence for increased levels of plasminogen inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease
49. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
50. Extrinsic plasminogen activator levels in clinical plasma samples
51. Homocysteine and vascular damage